UK-headquartered Essential Pharma will commercialise Nordmark’s pancreas powder 25,000 gastro-resistant capsules in the UK
The partnership brings two of Lilly's obesity treatments to one of the world's largest digital health platforms
Incident backlogs and delayed investigations choke production
Desloratadine Tablets launch complements Morepen’s broader API, R&D and CDMO growth strategy
The product made its global debut at SupplySide Global in Las Vegas, one of the world's largest gatherings of the dietary supplement, food and beverage industries
The Hyderabad-based CRDMO also reported a 20% increase in EBITDA to Rs. 187 crore
The company expects a stronger second half, projecting year-on-year growth in both revenue and EBITDA, backed by improving business visibility
The pharmaceutical leader crossed a significant milestone as its quarterly revenue from operations grew 11.03% YoY
Revenue climbs 23% on strong business growth; CDMO business surges 31%
Shilpa Medicare posted an EBITDA of Rs. 142 crore
The profit drop was driven by a sharp escalation in total expenses
The operational efficiency of Marksans Pharma saw massive acceleration
The company's consolidated total revenue from operations for the July–September quarter fell 29.8% to Rs. 4,247.32 crore
Its Rs 280 crore capital expenditure programme remains on track for completion by FY27, with Rs 160 crore already deployed
Operating performance also strengthened significantly, with consolidated EBITDA climbing 55% year-on-year to Rs 36.52 crore
The biopharma division of IGL reported net revenue of Rs 246 crore, EBITDA of Rs 29 crore and a gross margin of 40.1% in FY26
International operations emerged as the biggest growth driver, posting a 34.5% increase in revenue to Rs 16,652 million
Subscribe To Our Newsletter & Stay Updated
